Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leukemia

Showing results (1511-1520 of 9,628) with videos related to

Pageof 963
Sort By:
Leukemia|August 27, 2013
Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemiaD Allegra, V Bilan, A Garding, et al.
Leukemia|September 19, 2013
VTD consolidation, without bisphosphonates, reduces bone resorption and is associated with a very low incidence of skeletal-related events in myeloma patients post ASCTE Terpos, D Christoulas, E Kastritis, et al.
Leukemia|September 19, 2013
DNA methylation of membrane-bound tyrosine phosphatase genes in acute lymphoblastic leukaemiaW S Stevenson, O G Best, A Przybylla, et al.
Leukemia|September 19, 2013
Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasmsF Traina, V Visconte, P Elson, et al.
Leukemia|September 1, 1990
Immunophenotypic and HLA studies in childhood acute lymphoblastic leukemia in Trinidad, West IndiesE S Cameron, W B Labastide, V Wilson, et al.
Leukemia|July 1, 1990
Electric field-mediated gene transfer into K562 cells: optimization of parameters affecting efficiencyG M Croaker, E J Wass, H J Iland
Leukemia|June 12, 2013
Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276J Schmidt, E Braggio, K M Kortuem, et al.
Leukemia|June 13, 2013
Epigenetics in clinical practice: the examples of azacitidine and decitabine in myelodysplasia and acute myeloid leukemiaE H Estey
Leukemia|June 22, 2013
Monosomal karyotype in MDS: explaining the poor prognosis?J Schanz, H Tüchler, F Solé, et al.
Leukemia|March 6, 2013
Peripheral artery occlusive disease in chronic phase chronic myeloid leukemia patients treated with nilotinib or imatinibT D Kim, D Rea, M Schwarz, et al.
Pageof 963

Showing results (1511-1520 of 9,628) with videos related to

Sort By:
Pageof 963
Leukemia|August 27, 2013
Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemiaD Allegra, V Bilan, A Garding, et al.
Leukemia|September 19, 2013
VTD consolidation, without bisphosphonates, reduces bone resorption and is associated with a very low incidence of skeletal-related events in myeloma patients post ASCTE Terpos, D Christoulas, E Kastritis, et al.
Leukemia|September 19, 2013
DNA methylation of membrane-bound tyrosine phosphatase genes in acute lymphoblastic leukaemiaW S Stevenson, O G Best, A Przybylla, et al.
Leukemia|September 19, 2013
Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasmsF Traina, V Visconte, P Elson, et al.
Leukemia|September 1, 1990
Immunophenotypic and HLA studies in childhood acute lymphoblastic leukemia in Trinidad, West IndiesE S Cameron, W B Labastide, V Wilson, et al.
Leukemia|July 1, 1990
Electric field-mediated gene transfer into K562 cells: optimization of parameters affecting efficiencyG M Croaker, E J Wass, H J Iland
Leukemia|June 12, 2013
Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276J Schmidt, E Braggio, K M Kortuem, et al.
Leukemia|June 13, 2013
Epigenetics in clinical practice: the examples of azacitidine and decitabine in myelodysplasia and acute myeloid leukemiaE H Estey
Leukemia|June 22, 2013
Monosomal karyotype in MDS: explaining the poor prognosis?J Schanz, H Tüchler, F Solé, et al.
Leukemia|March 6, 2013
Peripheral artery occlusive disease in chronic phase chronic myeloid leukemia patients treated with nilotinib or imatinibT D Kim, D Rea, M Schwarz, et al.
Pageof 963